Literature DB >> 2745931

Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid glands.

C Broussolle1, X Ducottet, C Martin, Y Barbier, H Bornet, G Noel, J Orgiazzi.   

Abstract

Treatment of amiodarone iodine-induced thyrotoxicosis is often unsuccessful. Nevertheless, severe forms require a rapidly efficient therapy. Twelve patients with severe amiodarone iodine-induced thyrotoxicosis, as demonstrated on clinical and biological findings, were studied. After amiodarone withdrawal, 6 patients (group A) were treated with thionamides alone (carbimazole 60 mg daily and benzylthiouracile 1.5 g daily), and 6 patients (group B) received in addition to the same antithyroid drugs prednisone, 0.50 to 1.25 mg/kg/day for 40 days; in group A, T4 levels did not change over the study period of 40 days; T3 levels decreased only after 30 days; clinical status did not improve. In group B: T3 and T4 levels decreased dramatically at 10 days of treatment, to values significantly lower than in group A; clinical improvement occurred mainly in patients treated with high doses of prednisone; elevated thyroglobulin levels diminished rapidly. Improvement was maintained after cessation of prednisone. The rapid effect of prednisone suggests an impairement of proteolysis of thyroglobulin possibly due to a lysosomal action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745931     DOI: 10.1007/bf03349916

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  Prednisone in amiodarone-induced thyrotoxicosis.

Authors:  C Wimpfheimer; M Stäubli; J Schädelin; H Studer
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-19

2.  [Efficacy of dexamethasone in the treatment of hyperthyroidism caused by amiodarone].

Authors:  C Simon; J L Schlienger; J Cherfan; G Roul; F Vignon; G Chabrier; M Imler
Journal:  Presse Med       Date:  1984-12-15       Impact factor: 1.228

3.  Amiodarone--benefits and risks in perspective.

Authors:  H H Rotmensch; B Belhassen; R K Ferguson
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

4.  Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; M Lenziardi; L Baschieri; L E Braverman; A Pinchera
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

5.  Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).

Authors:  I J Chopra; D E Williams; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

6.  Iodine-induced thyrotoxicosis in apparently normal thyroid glands.

Authors:  J C Savoie; J P Massin; P Thomopoulos; F Leger
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

7.  Acute effects of corticosteroids on thyroid activity in Graves' disease.

Authors:  D E Williams; I J Chopra; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

8.  Effects of chronic administration of amiodarone on kinetics of metabolism of iodothyronines.

Authors:  R Kannan; M Ookhtens; I J Chopra; B N Singh
Journal:  Endocrinology       Date:  1984-11       Impact factor: 4.736

9.  Thyroid iodine content measured by x-ray fluorescence in amiodarone-induced thyrotoxicosis: concise communication.

Authors:  A F Léger; P Fragu; P Rougier; M F Laurent; M Tubiana; J C Savoie
Journal:  J Nucl Med       Date:  1983-07       Impact factor: 10.057

Review 10.  Amiodarone: historical development and pharmacologic profile.

Authors:  B N Singh
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

View more
  9 in total

1.  Carbimazole--resistant thyrotoxicosis.

Authors:  B Corvilain; P Schinohoritis
Journal:  Postgrad Med J       Date:  1997-10       Impact factor: 2.401

Review 2.  Amiodarone-induced thyroid disorders: a clinical review.

Authors:  K C Loh
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

3.  Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis.

Authors:  F Bogazzi; E Dell'Unto; M L Tanda; L Tomisti; C Cosci; F Aghini-Lombardi; C Sardella; A Pinchera; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

Review 4.  Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.

Authors:  C M Newman; A Price; D W Davies; T A Gray; A P Weetman
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

5.  Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.

Authors:  F Bogazzi; E Martino; E Dell'Unto; S Brogioni; C Cosci; F Aghini-Lombardi; C Ceccarelli; A Pinchera; L Bartalena; L E Braverman
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 6.  Drug-induced thyroid disorders.

Authors:  N J Gittoes; J A Franklyn
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

7.  Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.

Authors:  F Aghini-Lombardi; S Mariotti; P V Fosella; L Grasso; A Pinchera; L E Braverman; E Martino
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

8.  Comparison of methimazole/hydrocortisone ointment with oral methimazole in patients with graves disease: A prospective, randomized, open-label, parallel-group, 18-month study.

Authors:  Ling Chen; Hong-Qing Wang; Yan-Yan Gao; Jun Liang; Men Wang; Jie Bai; Wen-Bo Qi; Jun-Sheng Zhang; Jian Zhang; Juan-Qing Ren; Hui-Qing Li
Journal:  Curr Ther Res Clin Exp       Date:  2008-08

9.  Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: experience at a tertiary care centre in oman.

Authors:  H Farhan; A Albulushi; A Taqi; A Al-Hashim; K Al-Saidi; K Al-Rasadi; A Al-Mazroui; I Al-Zakwani
Journal:  Open Cardiovasc Med J       Date:  2013-11-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.